{"gene":"ATF1","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":1991,"finding":"ATF-1 contains a consensus PKA phosphorylation site and is capable of dimerizing with CREB; both ATF-1 homodimers and ATF-1/CREB heterodimers bind to the CRE but not the phorbol ester response element. ATF-1 mediates transcriptional activation in response to cAMP-dependent protein kinase A, and is more responsive than CREB to cAMP due to its smaller effect on basal expression.","method":"cDNA sequencing, in vitro dimerization assay, EMSA/DNA binding, transient transfection reporter assay with PKA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biochemical methods (DNA binding, dimerization, reporter assay, sequence analysis) in a single foundational study; widely replicated","pmids":["1655749"],"is_preprint":false},{"year":1993,"finding":"The t(12;22)(q13;q12) chromosomal translocation fuses the N-terminal domain of EWS to the bZIP domain of ATF-1, producing a chimeric EWS/ATF1 protein associated with malignant melanoma of soft parts (clear cell sarcoma).","method":"RT-PCR, cDNA cloning, sequencing of hybrid transcripts from tumor specimens","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct molecular cloning and sequencing of fusion transcripts, replicated across multiple independent studies","pmids":["8401579"],"is_preprint":false},{"year":1993,"finding":"ATF1 contains key serine residues required for a phosphorylation-induced conformational change; phosphorylation is modulated by ATF1 homodimerization and by ATF1 binding to DNA. One critical serine is not conserved in CREB/CREM, suggesting a specialized function of ATF1.","method":"In vitro phosphorylation assay, mutagenesis of serine residues, DNA binding stability assay","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro phosphorylation and mutagenesis in a single study, no cellular validation reported in abstract","pmids":["8414969"],"is_preprint":false},{"year":1995,"finding":"ATF-1 and CREB-1 bind constitutively to the HIF-1 DNA recognition site as homodimers or heterodimers, revealing a new binding specificity for ATF-1/CREB-1. PKA signaling (but not PKC) is involved in oxygen-sensing activity at this element.","method":"EMSA with competitor oligonucleotides and monoclonal antibody supershift, recombinant protein binding assay, reporter gene assay","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal EMSA with antibody supershift and recombinant protein, plus reporter assay; single lab","pmids":["8524640"],"is_preprint":false},{"year":1995,"finding":"EWS/ATF1 fusion protein acts as a strong constitutive transcriptional activator of some ATF1-binding promoters and represses others; the pattern of promoter activation in transfected cells correlates with promoter activity in MMSP-derived cell lines, indicating endogenous EWS/ATF1 de-regulates transcription.","method":"Transient transfection, reporter gene assay in JEG3 cells and MMSP cell lines","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays in multiple cell contexts, correlative but mechanistically informative; single lab","pmids":["7753552"],"is_preprint":false},{"year":1996,"finding":"FGF and cellular stress activate CREB and ATF-1 via p38 MAP kinase → MAPKAP kinase-2 signaling. MAPKAP kinase-2 phosphorylates CREB at Ser133 in vitro, and FGF/stress-induced phosphorylation of both CREB and ATF-1 is blocked by the p38 inhibitor SB 203580 at similar concentrations. Transfection of RK/p38 (but not p44 MAP kinase) activates Gal4-CREB-dependent transcription via Ser133.","method":"In vitro kinase assay, dominant negative Ras transfection, specific kinase inhibitor (SB203580), Gal4 reporter assay, cell fractionation kinase activity assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro phosphorylation assay plus cellular pharmacological inhibition plus dominant-negative experiments plus reporter assay; multiple orthogonal methods","pmids":["8887554"],"is_preprint":false},{"year":1997,"finding":"ATF-1 binds the ZII element of the EBV BZLF1 promoter (core motif TGACATCA) and transactivates it; deletion of ATF-1's DNA binding domain abolishes this transactivation. UV cross-linking identified ATF-1 as a 46/51 kDa protein within ZII-binding complexes.","method":"EMSA, UV cross-linking, antibody immunoprecipitation, cotransfection reporter assay with deletion mutants","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA, UV cross-linking and reporter assay with domain deletion mutants; single lab","pmids":["9018131"],"is_preprint":false},{"year":1997,"finding":"Phosphorylation of ATF-1 at Ser63 enhances its DNA binding activity in both homodimeric and heterodimeric (ATF-1/CREB) forms, and stimulates in vitro transcription from the Na,K-ATPase α1 subunit gene promoter, which has an asymmetrical ATF/CRE site.","method":"In vitro dephosphorylation, EMSA, in vitro transcription assay","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical assays (EMSA + transcription), single lab, no mutagenesis of Ser63 directly reported in this abstract","pmids":["9016641"],"is_preprint":false},{"year":1997,"finding":"ATF1 and CREB bind to two ATF/CRE motifs in the histone H4 promoter; ATF1 exists as two isoforms that partition differentially between nuclear matrix and non-matrix compartments, and both Site I and Site IV (nuclear matrix-associated) ATF/CRE motifs are required for ATF1- and CREB-induced transactivation of the H4 promoter.","method":"Protein-DNA interaction assays (EMSA), subnuclear fractionation, site-directed mutagenesis, transactivation reporter assay","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical methods (EMSA, fractionation, mutagenesis, reporter), single lab","pmids":["9398163"],"is_preprint":false},{"year":1998,"finding":"EWS/ATF1 transcriptional activation does not require dimerization with other ATF family members; the EWS activation domain (EAD) can act directly and determinants of transactivation are dispersed throughout the EAD and cooperate synergistically.","method":"Mutational analysis in mammalian cells, reporter assay, yeast transactivation assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis with reporter assays across mammalian and yeast systems; single lab","pmids":["9569031"],"is_preprint":false},{"year":1998,"finding":"Dominant-negative ATF1 (point mutation in DNA binding domain) expressed stably in PC12D cells suppresses CRE reporter activity, reduces immediate early gene mRNA induction by forskolin, and blocks cAMP-induced neurite outgrowth, without affecting NGF-induced differentiation. This implicates the CREB/ATF1 heterodimer specifically in cAMP-dependent neuronal differentiation.","method":"Stable transfection of dominant-negative ATF1RL, CRE reporter assay, Northern blot for immediate early genes, morphological assessment of neurite outgrowth","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — stable cell line loss-of-function with defined phenotypic readout and reporter assay; single lab","pmids":["9489722"],"is_preprint":false},{"year":1999,"finding":"Transcription of the TGF-β2 gene is dependent on CRE/ATF sites bound by CREB and ATF-1; the coactivators p300 and CBP up-regulate TGF-β2 promoter activity when CREB and ATF-1 are expressed together with kinases that phosphorylate CREB at Ser133 and ATF-1 at Ser63. Serine 133-phosphorylated CREB accumulates in nuclei of differentiated but not undifferentiated F9 cells.","method":"Transient transfection, co-expression with kinases, reporter assay, western blot for phospho-CREB","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter + co-expression + western blot; single lab, multiple methods","pmids":["10567368"],"is_preprint":false},{"year":2000,"finding":"BRCA1 physically interacts with ATF1 via the BRCA1 RING finger domain, as demonstrated in vitro, in yeast two-hybrid, and by co-immunoprecipitation in human cells. BRCA1 stimulates transcription from a CRE reporter and from the TNF-α promoter in a CRE-dependent manner.","method":"Yeast two-hybrid, in vitro pull-down, co-immunoprecipitation in human cells, transient transfection reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal interactions confirmed in three systems (yeast, in vitro, human cells) with functional reporter validation","pmids":["10945975"],"is_preprint":false},{"year":2001,"finding":"Phosphorylation of serine 266 in the EWS IQ domain regulates the transcriptional activity of EWS/ATF1 (and EWS/FLI1). Elimination of phosphorylation significantly reduced DNA binding and reporter activation; phosphomimetic mutation partially restored wild-type activity. Phosphorylation also mediates cellular compartmentalization of EWS/ATF1.","method":"Mutagenesis, EMSA, luciferase reporter assay, cellular fractionation","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro DNA binding + mutagenesis + reporter assay; single lab","pmids":["11313922"],"is_preprint":false},{"year":2001,"finding":"Degenerate Hexapeptide Repeats (DHRs) in the EWS activation domain contain conserved tyrosines that are required for transcriptional activation by EWS/ATF1; small regions (~30 residues) of the EAD trans-cooperate to produce potent tyrosine-dependent transactivation.","method":"Mutational analysis of EAD repeat elements, reporter assay in mammalian cells","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic mutagenesis with reporter assays; single lab","pmids":["11464282"],"is_preprint":false},{"year":2002,"finding":"MSK1 and MSK2 are required for stress-induced phosphorylation of both CREB and ATF1 in primary fibroblasts. Mitogen-induced phosphorylation of CREB and ATF1 is greatly reduced but not abolished in MSK1/MSK2 double-knockout cells. Loss of both MSK1 and MSK2 reduces c-fos and junB transcription by ~50% in response to anisomycin or UV-C.","method":"Mouse MSK1/MSK2 single and double knockouts, immunoblot for phospho-CREB/ATF1, Northern blot for immediate early genes","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout (double KO) with biochemical and transcriptional readouts; strong causal evidence","pmids":["11909979"],"is_preprint":false},{"year":2002,"finding":"ATF1 phosphorylation at Ser63 by MSK1 (activated downstream of ERK1/2) is required for EGF-induced c-jun promoter activation. A Ser63→Ala ATF1 mutant blocks EGF induction of transfected c-jun; kinase-dead MSK1 also blocks EGF induction. The ERK pathway (blocked by MEK1 inhibitor U0126 or dominant-negative MEK1) is required for MSK1 activation and ATF1 phosphorylation.","method":"Site-directed mutagenesis of ATF1 Ser63, dominant-negative kinase constructs, pharmacological inhibitors, reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of phosphorylation site combined with dominant-negative and pharmacological approaches with defined reporter readout; single lab with multiple orthogonal methods","pmids":["12414794"],"is_preprint":false},{"year":1999,"finding":"Intracellular delivery of an anti-ATF1 single-chain antibody (scFv4) into the CCS cell line SU-CCS-1 reduces CRE-driven reporter activity by 90% and causes loss of viability and apoptosis, demonstrating that EWS/ATF1 DNA-binding activity is required for maintenance of CCS tumor cell viability.","method":"Intracellular scFv antibody delivery, CRE reporter assay, TUNEL/flow cytometry apoptosis assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional antibody knockdown with multiple cellular readouts; single lab","pmids":["10574952"],"is_preprint":false},{"year":2005,"finding":"ATF-1 is an essential transcriptional activator of NOX1 (NADPH oxidase 1) in vascular smooth muscle cells. PGF2α- or PDGF-induced NOX1 mRNA induction is suppressed by mitochondrial respiratory chain inhibitors acting upstream of ATF-1 phosphorylation; ATF-1 siRNA knockdown reduces NOX1 induction, and ATF-1 overexpression rescues NOX1 induction suppressed by oligomycin.","method":"Luciferase reporter assay, RNA interference (siRNA), overexpression rescue, pharmacological inhibitors","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi knockdown + overexpression rescue + reporter assay; single lab, multiple methods","pmids":["15491278"],"is_preprint":false},{"year":2006,"finding":"Loss of CREB/ATF1 (by siRNA) blocks adipogenic conversion of 3T3-L1 cells even in the presence of ectopically expressed C/EBPα, C/EBPβ, or PPARγ2 individually, and prevents expression of PPARγ, C/EBPα, and adiponectin, indicating CREB/ATF1 acts downstream of or in parallel with master adipogenic regulators.","method":"siRNA depletion, ectopic expression of adipogenic regulators, adipogenesis assays (lipid accumulation, adipokine expression)","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi loss-of-function with epistasis via ectopic expression rescue; single lab","pmids":["17071615"],"is_preprint":false},{"year":2007,"finding":"PIAS3 interacts with ATF1 (identified by yeast two-hybrid screening) and antagonizes ATF1's function as a transcriptional repressor of the ferritin H ARE by decreasing ATF1 binding to the ARE. ATF1 is sumoylated, but PIAS3 does not appear to play a major role in SUMO1-mediated ATF1 sumoylation. ATF1 knockdown increases ferritin H expression.","method":"Yeast two-hybrid, co-immunoprecipitation, EMSA, siRNA knockdown, reporter assay, sumoylation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid, Co-IP, EMSA, and RNAi in combination; single lab","pmids":["17565989"],"is_preprint":false},{"year":2008,"finding":"ATF-1, identified via a transcription factor array screen, binds a 10-bp region of the UCP3 promoter (identified by site-directed mutagenesis and ChIP) and is required for hypoxia-induced UCP3 upregulation. ATF-1 is phosphorylated during hypoxia via p38 MAP kinase; shRNA knockdown of ATF-1 prevents hypoxia-mediated UCP3 upregulation.","method":"Transcription factor cDNA array screen, luciferase reporter + site-directed mutagenesis, ChIP, shRNA knockdown, western blot for phospho-ATF-1, p38 pharmacological inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal methods including mutagenesis, ChIP, shRNA, and pharmacological inhibition in a single study","pmids":["18579531"],"is_preprint":false},{"year":2010,"finding":"RSK2 phosphorylates ATF1 at Ser-63 and enhances ATF1 transcriptional activity. In vitro pulldown assays combined with crystal structure docking show eriodictyol binds the RSK2 N-terminal kinase domain, inhibiting RSK2 activity and ATF1 phosphorylation. Knockdown of RSK2 or ATF1 suppresses Ras-mediated focus formation, indicating RSK2-ATF1 signaling drives neoplastic transformation.","method":"In vitro kinase assay, crystal structure docking, in vitro pulldown, RNAi knockdown, focus formation assay, reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay identifying novel substrate, structural docking + pulldown + RNAi functional validation; multiple orthogonal methods","pmids":["21098035"],"is_preprint":false},{"year":2012,"finding":"miR-34c directly binds the 3'UTR of ATF1 and reduces ATF1 protein (but not mRNA) levels; ATF1 knockdown decreases the Bcl-2/Bax ratio and induces apoptosis in GC-2 cells; miR-34c inhibition cannot rescue apoptosis in ATF1-knockdown cells, placing ATF1 downstream of miR-34c in the regulation of germ cell apoptosis.","method":"Luciferase 3'UTR reporter assay, siRNA knockdown, miR-34c inhibitor, western blot, flow cytometry for apoptosis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — 3'UTR reporter + epistasis rescue experiment + knockdown; single lab","pmids":["22479460"],"is_preprint":false},{"year":2013,"finding":"EWS/ATF1 expression in neural crest-derived cells in mice induces CCS-like sarcomas; EWS/ATF1 directly induces Fos expression in an ERK-independent manner, and FOS is required for EWS/ATF1-associated tumor cell proliferation (FOS siRNA attenuates growth).","method":"Inducible transgenic mouse model, lineage tracing, siRNA knockdown, gene expression analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible mouse model with lineage tracing plus siRNA functional validation; multiple orthogonal approaches","pmids":["23281395"],"is_preprint":false},{"year":2014,"finding":"ATF1 interacts with HSF1 and is recruited to the HSP70 promoter in response to heat shock. The HSF1 transcription complex requires ATF1 phosphorylation for incorporation of BRG1 and p300/CBP. ATF1-BRG1 promotes active chromatin and HSP70 expression during heat shock; ATF1-p300/CBP accelerates shutdown of HSF1 DNA-binding during recovery, possibly via HSF1 acetylation. ATF1 markedly affects heat shock resistance.","method":"Co-immunoprecipitation, ChIP-seq, reporter assay, domain deletion/phosphorylation mutants, RNAi knockdown, heat shock survival assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, ChIP-seq, mutagenesis, and functional assays in combination; single lab with multiple orthogonal methods","pmids":["25312646"],"is_preprint":false},{"year":2022,"finding":"EWSR1-ATF1 displays a distinct DNA binding pattern that requires the EWSR1 domain and promotes ATF1 retargeting to new distal enhancer sites, leading to chromatin activation and establishment of a 3D regulatory network controlling oncogenic and differentiation gene signatures. EWSR1-ATF1 depletion reconfigures 3D connectivity and activates neural crest developmental programs.","method":"ChIP-seq, ATAC-seq, Hi-C/3D chromatin conformation, EWSR1-ATF1 depletion, RNA-seq in CCS cells","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal epigenomic and 3D chromatin methods combined with depletion experiments; single study with comprehensive mechanistic depth","pmids":["35477713"],"is_preprint":false},{"year":2019,"finding":"ATF1 facilitates cell proliferation and promotes CRC xenograft growth by affecting cell apoptosis. Two risk variants in the ATF1 promoter and first intron facilitate a promoter-enhancer interaction mediated by SP1 and GATA3, upregulating ATF1 expression. ChIP-seq shows ATF1 activates a subset of target genes including BRAF, NRAS, MYC, BIRC2, and MAML2 related to apoptosis, Wnt, TGF-β, and MAPK pathways.","method":"RNAi screen, xenograft growth assay, ChIP-seq, RNA-seq, chromatin conformation assay, luciferase reporter","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi screen + ChIP-seq + RNA-seq + reporter; single lab, multiple methods but complex composite study","pmids":["31204011"],"is_preprint":false},{"year":2019,"finding":"EWS/ATF1 binds cell type-specific enhancer regions in CCS cells; epigenetic silencing at these enhancers induces senescence and inhibits CCS cell growth through altered EWS/ATF1 binding. EWS/ATF1 expression induces oncogene-induced senescence in most cell types but prevents it in sarcoma-permissive cells, and Tppp3-expressing cells in peripheral nerves are identified as a cell-of-origin.","method":"iPSC reprogramming, inducible EWS/ATF1 expression, ChIP-seq, epigenetic silencing, lineage tracing","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible system, ChIP-seq, and lineage tracing with functional epigenetic perturbation; multiple orthogonal methods","pmids":["31488818"],"is_preprint":false}],"current_model":"ATF1 is a bZIP transcription factor of the CREB/ATF family that binds CRE elements as homodimers or heterodimers with CREB, and is activated by phosphorylation at Ser63 (by MSK1, RSK2, and MAPKAP kinase-2 downstream of p38, ERK, and cAMP/PKA pathways), which enhances its DNA binding, recruits co-activators p300/CBP, and drives transcription of target genes including c-jun, NOX1, UCP3, and HSP70; in cancer, the EWS/ATF1 chromosomal fusion protein constitutively activates ATF-binding promoters, retargets ATF1 to novel distal enhancers via the EWSR1 domain, rewires 3D chromatin architecture to establish oncogenic gene programs, and is required for CCS tumor cell viability."},"narrative":{"mechanistic_narrative":"ATF1 is a bZIP transcription factor of the CREB/ATF family that binds CRE/ATF DNA elements as homodimers or as heterodimers with CREB and drives cAMP- and stress-responsive transcription [PMID:1655749]. Its activity is gated by phosphorylation at Ser63, which induces a conformational change, enhances DNA binding by both homo- and heterodimers, and stimulates transcription from ATF/CRE promoters [PMID:8414969, PMID:9016641]; this phosphorylation is executed by multiple kinases converging from distinct signaling inputs — MAPKAP kinase-2 downstream of p38 upon FGF/stress [PMID:8887554], MSK1/MSK2 in response to stress and mitogens [PMID:11909979], MSK1 downstream of ERK1/2 for EGF-induced c-jun activation [PMID:12414794], and RSK2, which couples ATF1 to Ras-mediated neoplastic transformation [PMID:21098035]. Through these inputs ATF1 controls a broad target program: it activates c-jun [PMID:12414794], NOX1 in vascular smooth muscle [PMID:15491278], hypoxia-induced UCP3 [PMID:18579531], and TGF-β2 via recruitment of p300/CBP coactivators [PMID:10567368], and it represses the ferritin H antioxidant-response element, an activity antagonized by PIAS3 [PMID:17565989]. ATF1 is integral to cellular stress and differentiation responses, partnering with HSF1 to recruit BRG1 and p300/CBP to the HSP70 promoter during heat shock [PMID:25312646], and acting with CREB as a required factor in cAMP-dependent neuronal differentiation [PMID:9489722] and adipogenesis [PMID:17071615]. ATF1 also interacts physically with BRCA1, which stimulates CRE-dependent transcription [PMID:10945975]. In cancer, the t(12;22) translocation fuses the EWS N-terminal activation domain to the ATF1 bZIP domain, producing EWS/ATF1, a constitutive transcriptional activator that causes clear cell sarcoma [PMID:8401579, PMID:7753552]; EWS/ATF1 DNA-binding is required for tumor cell viability [PMID:10574952], retargets ATF1 to novel distal enhancers and rewires 3D chromatin architecture to establish oncogenic gene programs [PMID:35477713, PMID:31488818], and induces FOS to drive proliferation [PMID:23281395].","teleology":[{"year":1991,"claim":"Established ATF1 as a CRE-binding bZIP factor that dimerizes with CREB and mediates cAMP/PKA-responsive transcription, defining its founding identity.","evidence":"cDNA sequencing, in vitro dimerization, EMSA, and PKA-driven reporter assays","pmids":["1655749"],"confidence":"High","gaps":["Endogenous target genes not yet identified","In vivo physiological role unaddressed"]},{"year":1993,"claim":"Identified the t(12;22) EWS/ATF1 fusion linking the ATF1 bZIP domain to the EWS activation domain in clear cell sarcoma, opening the oncogenic dimension of ATF1 biology.","evidence":"RT-PCR and cDNA cloning/sequencing of fusion transcripts from tumor specimens","pmids":["8401579"],"confidence":"High","gaps":["Transcriptional consequences of the fusion not yet defined","Cell of origin unknown"]},{"year":1993,"claim":"Defined critical serine residues whose phosphorylation induces a conformational change modulated by dimerization and DNA binding, with one serine unique to ATF1, hinting at a specialized activation mode.","evidence":"In vitro phosphorylation, serine mutagenesis, and DNA binding stability assays","pmids":["8414969"],"confidence":"Medium","gaps":["No cellular validation in this study","Responsible kinase not identified"]},{"year":1995,"claim":"Showed EWS/ATF1 acts as a strong constitutive activator (and selective repressor) of ATF1-binding promoters, mechanistically distinguishing the fusion from wild-type ATF1.","evidence":"Transient transfection reporter assays in JEG3 and MMSP cell lines","pmids":["7753552"],"confidence":"Medium","gaps":["Endogenous fusion target genes not mapped","Correlative promoter activity, not direct binding"]},{"year":1996,"claim":"Placed ATF1 phosphorylation downstream of the p38 MAPK → MAPKAP kinase-2 cascade in response to FGF and cellular stress, establishing a stress-signaling input.","evidence":"In vitro kinase assay, dominant-negative Ras, SB203580 inhibition, Gal4 reporter assays","pmids":["8887554"],"confidence":"High","gaps":["Direct ATF1 (vs CREB) phosphorylation site detail limited","Downstream target genes not enumerated"]},{"year":1997,"claim":"Demonstrated that Ser63 phosphorylation enhances ATF1 DNA binding and stimulates transcription, identifying the key activating modification.","evidence":"In vitro dephosphorylation, EMSA, and in vitro transcription from the Na,K-ATPase α1 promoter","pmids":["9016641"],"confidence":"Medium","gaps":["Direct Ser63 mutagenesis not reported here","Cellular kinase responsible not assigned"]},{"year":1997,"claim":"Extended ATF1's promoter repertoire to viral (EBV BZLF1 ZII) and cellular (histone H4) targets and showed isoform-specific subnuclear partitioning, broadening its functional context.","evidence":"EMSA, UV cross-linking, IP, subnuclear fractionation, and reporter assays with deletion/mutagenesis","pmids":["9018131","9398163"],"confidence":"Medium","gaps":["Functional significance of isoform partitioning unclear","Single-lab promoter studies"]},{"year":1998,"claim":"Dissected the EWS activation domain of the fusion, showing transactivation is dimerization-independent with determinants dispersed across the EAD acting synergistically.","evidence":"Mutational analysis with reporter assays in mammalian and yeast systems","pmids":["9569031"],"confidence":"Medium","gaps":["Coactivators recruited by the EAD not identified","Endogenous targets untested"]},{"year":1999,"claim":"Demonstrated that EWS/ATF1 DNA-binding activity is essential for clear cell sarcoma tumor cell survival, validating it as a therapeutic dependency.","evidence":"Intracellular anti-ATF1 scFv delivery into SU-CCS-1 cells with CRE reporter and apoptosis assays","pmids":["10574952"],"confidence":"Medium","gaps":["Mechanism of cell death downstream of fusion not defined","Single cell line"]},{"year":1999,"claim":"Linked ATF1/CREB and p300/CBP coactivation to TGF-β2 transcription, tying ATF1 phosphorylation to coactivator-dependent gene induction during differentiation.","evidence":"Transient transfection, kinase co-expression, reporter assays, phospho-CREB western blot","pmids":["10567368"],"confidence":"Medium","gaps":["Direct ATF1 occupancy at the TGF-β2 promoter not shown by ChIP","Relative ATF1 vs CREB contribution unresolved"]},{"year":2000,"claim":"Identified BRCA1 as a direct physical partner of ATF1 that stimulates CRE-dependent transcription, connecting ATF1 to a tumor-suppressor protein.","evidence":"Yeast two-hybrid, in vitro pull-down, co-IP in human cells, and CRE/TNF-α reporter assays","pmids":["10945975"],"confidence":"High","gaps":["Physiological context of the interaction unclear","Effect on endogenous BRCA1 target genes untested"]},{"year":2001,"claim":"Refined fusion regulation by showing EWS Ser266 phosphorylation and conserved EAD tyrosines in hexapeptide repeats are required for EWS/ATF1 transactivation and compartmentalization.","evidence":"Mutagenesis, EMSA, luciferase reporter assays, and cellular fractionation","pmids":["11313922","11464282"],"confidence":"Medium","gaps":["Kinase phosphorylating Ser266 not identified","Single-lab biochemical studies"]},{"year":2002,"claim":"Genetically assigned MSK1/MSK2 as the kinases mediating stress- and mitogen-induced CREB/ATF1 phosphorylation and downstream immediate-early gene transcription.","evidence":"MSK1/MSK2 single and double knockout mice with phospho-immunoblot and Northern blot readouts","pmids":["11909979"],"confidence":"High","gaps":["Residual phosphorylation indicates additional kinases","ATF1-specific (vs CREB) target effects not separated"]},{"year":2002,"claim":"Established the ERK → MSK1 → ATF1 Ser63 axis as required for EGF-induced c-jun activation, defining a specific mitogenic output of ATF1.","evidence":"Ser63→Ala mutagenesis, kinase-dead MSK1, U0126/dominant-negative MEK1, and reporter assays","pmids":["12414794"],"confidence":"High","gaps":["Endogenous c-jun occupancy by ATF1 not directly mapped","Single-lab reporter system"]},{"year":2005,"claim":"Identified NOX1 as an ATF1 target in vascular smooth muscle, coupling mitochondrial/redox signaling to ATF1-dependent NADPH oxidase induction.","evidence":"Luciferase reporter, ATF1 siRNA, overexpression rescue, and pharmacological inhibitors","pmids":["15491278"],"confidence":"Medium","gaps":["Direct ATF1 binding to NOX1 promoter by ChIP not shown","Single cell type"]},{"year":2006,"claim":"Placed CREB/ATF1 as an essential factor for adipogenic conversion acting downstream of or parallel to master adipogenic regulators.","evidence":"siRNA depletion with ectopic expression of C/EBP and PPARγ and adipogenesis assays in 3T3-L1 cells","pmids":["17071615"],"confidence":"Medium","gaps":["Direct adipogenic target genes of ATF1 not defined","ATF1 vs CREB contribution not separated"]},{"year":2007,"claim":"Identified PIAS3 as an ATF1 interactor antagonizing ATF1's repressor function at the ferritin H ARE and showed ATF1 is SUMOylated, revealing repressive and post-translational regulatory facets.","evidence":"Yeast two-hybrid, co-IP, EMSA, siRNA, reporter, and sumoylation assays","pmids":["17565989"],"confidence":"Medium","gaps":["Functional role of ATF1 SUMOylation unresolved","PIAS3-ATF1 interaction not validated in vivo"]},{"year":2008,"claim":"Defined ATF1 as a direct, p38-phosphorylated activator of hypoxia-induced UCP3, mapping a precise promoter element and linking ATF1 to metabolic adaptation.","evidence":"TF array screen, reporter mutagenesis, ChIP, shRNA, phospho-immunoblot, p38 inhibition","pmids":["18579531"],"confidence":"High","gaps":["Generality across tissues untested","Cofactors at UCP3 promoter not identified"]},{"year":2010,"claim":"Identified RSK2 as a Ser63 ATF1 kinase whose activity drives Ras-mediated transformation, providing a pharmacologically targetable ATF1 signaling node.","evidence":"In vitro kinase assay, structural docking of eriodictyol, pulldown, RNAi, and focus formation assay","pmids":["21098035"],"confidence":"High","gaps":["In vivo tumor relevance of RSK2-ATF1 axis untested here","ATF1 target genes mediating transformation undefined"]},{"year":2012,"claim":"Placed ATF1 as a direct miR-34c target controlling the Bcl-2/Bax ratio and germ cell apoptosis, revealing post-transcriptional regulation of ATF1 levels.","evidence":"3'UTR luciferase reporter, siRNA, miR-34c inhibitor, western blot, apoptosis flow cytometry","pmids":["22479460"],"confidence":"Medium","gaps":["Direct apoptotic target genes of ATF1 not mapped","Single cell model"]},{"year":2013,"claim":"Demonstrated in vivo that EWS/ATF1 in neural crest cells induces CCS-like sarcomas and directly drives FOS expression required for proliferation, establishing an oncogenic transcriptional output.","evidence":"Inducible transgenic mouse model, lineage tracing, and FOS siRNA knockdown","pmids":["23281395"],"confidence":"High","gaps":["Full set of direct fusion targets not enumerated","Mechanism of ERK-independent Fos induction unclear"]},{"year":2014,"claim":"Revealed ATF1's role in the heat-shock response, where it partners with HSF1 and, in a phosphorylation-dependent manner, recruits BRG1 and p300/CBP to control HSP70 chromatin state and heat resistance.","evidence":"Co-IP, ChIP-seq, reporter assays, domain/phospho mutants, RNAi, and heat-shock survival assays","pmids":["25312646"],"confidence":"High","gaps":["Whether HSF1 acetylation by ATF1-p300 is direct unproven","Generality beyond HSP70 untested"]},{"year":2019,"claim":"Showed risk-variant-driven upregulation of ATF1 promotes colorectal cancer growth and that ATF1 directly activates a set of oncogenic targets, extending its tumor-promoting role beyond the fusion context.","evidence":"RNAi screen, xenograft assays, ChIP-seq, RNA-seq, chromatin conformation, and reporter assays","pmids":["31204011"],"confidence":"Medium","gaps":["Composite study with complex causal chains","Direct vs indirect target distinction incomplete"]},{"year":2022,"claim":"Resolved how the EWSR1 domain reprograms ATF1, retargeting it to novel distal enhancers and rewiring 3D chromatin to establish oncogenic and differentiation gene networks in CCS, with depletion reconfiguring connectivity and reactivating neural crest programs.","evidence":"ChIP-seq, ATAC-seq, Hi-C, EWSR1-ATF1 depletion, and RNA-seq in CCS cells; complemented by iPSC/enhancer silencing and lineage tracing (PMID 31488818)","pmids":["35477713","31488818"],"confidence":"High","gaps":["Determinants of enhancer selection by the EWSR1 domain not fully defined","Translational targetability of the rewired network untested"]},{"year":null,"claim":"How the diverse upstream kinase inputs are integrated to produce context-specific ATF1 target gene selection, and how wild-type ATF1 versus the EWS/ATF1 fusion differentially engage chromatin and coactivators, remain incompletely defined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of signal-to-target specificity","Genome-wide wild-type ATF1 occupancy map limited","Structural basis of EWS-domain-directed enhancer retargeting unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,4,11,18,21,25,27]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,7,8,21,26]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,11,13]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,16,21,25]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,15,16,22]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[5,21,25]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,4,24,26,28]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[10,19]}],"complexes":["CREB/ATF1 dimer","HSF1 transcription complex (HSP70 promoter)"],"partners":["CREB1","EWSR1","BRCA1","PIAS3","HSF1","P300/CBP","BRG1","MSK1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P18846","full_name":"Cyclic AMP-dependent transcription factor ATF-1","aliases":["Activating transcription factor 1","Protein TREB36"],"length_aa":271,"mass_kda":29.2,"function":"This protein binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in many viral and cellular promoters. Binds to the Tax-responsive element (TRE) of HTLV-I. Mediates PKA-induced stimulation of CRE-reporter genes. Represses the expression of FTH1 and other antioxidant detoxification genes. Triggers cell proliferation and transformation","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P18846/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ATF1","classification":"Not Classified","n_dependent_lines":54,"n_total_lines":1208,"dependency_fraction":0.04470198675496689},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ATF1","total_profiled":1310},"omim":[{"mim_id":"612160","title":"HISTIOCYTOMA, ANGIOMATOID FIBROUS","url":"https://www.omim.org/entry/612160"},{"mim_id":"607926","title":"HOST CELL FACTOR C2; HCFC2","url":"https://www.omim.org/entry/607926"},{"mim_id":"605537","title":"ACTIVATING TRANSCRIPTION FACTOR 6; ATF6","url":"https://www.omim.org/entry/605537"},{"mim_id":"165161","title":"ONCOGENE JUN-B; JUNB","url":"https://www.omim.org/entry/165161"},{"mim_id":"137070","title":"FUS RNA-BINDING PROTEIN; FUS","url":"https://www.omim.org/entry/137070"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ATF1"},"hgnc":{"alias_symbol":["TREB36"],"prev_symbol":[]},"alphafold":{"accession":"P18846","domains":[{"cath_id":"1.20.5","chopping":"226-271","consensus_level":"medium","plddt":94.9102,"start":226,"end":271}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P18846","model_url":"https://alphafold.ebi.ac.uk/files/AF-P18846-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P18846-F1-predicted_aligned_error_v6.png","plddt_mean":64.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ATF1","jax_strain_url":"https://www.jax.org/strain/search?query=ATF1"},"sequence":{"accession":"P18846","fasta_url":"https://rest.uniprot.org/uniprotkb/P18846.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P18846/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P18846"}},"corpus_meta":[{"pmid":"8887554","id":"PMC_8887554","title":"FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8887554","citation_count":569,"is_preprint":false},{"pmid":"8401579","id":"PMC_8401579","title":"EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts.","date":"1993","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8401579","citation_count":455,"is_preprint":false},{"pmid":"8824587","id":"PMC_8824587","title":"Conjugation, meiosis, and the osmotic stress response are regulated by Spc1 kinase through Atf1 transcription factor in fission yeast.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8824587","citation_count":376,"is_preprint":false},{"pmid":"11909979","id":"PMC_11909979","title":"MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11909979","citation_count":375,"is_preprint":false},{"pmid":"8824588","id":"PMC_8824588","title":"The Atf1 transcription factor is a target for the Sty1 stress-activated MAP kinase pathway in fission yeast.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8824588","citation_count":324,"is_preprint":false},{"pmid":"21484932","id":"PMC_21484932","title":"EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland.","date":"2011","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21484932","citation_count":292,"is_preprint":false},{"pmid":"8557039","id":"PMC_8557039","title":"Schizosaccharomyces pombe atf1+ encodes a transcription factor required for sexual development and entry into stationary phase.","date":"1995","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8557039","citation_count":230,"is_preprint":false},{"pmid":"1655749","id":"PMC_1655749","title":"The cAMP-regulated enhancer-binding protein ATF-1 activates transcription in response to cAMP-dependent protein kinase A.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1655749","citation_count":198,"is_preprint":false},{"pmid":"22510762","id":"PMC_22510762","title":"Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status.","date":"2012","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22510762","citation_count":195,"is_preprint":false},{"pmid":"8524640","id":"PMC_8524640","title":"The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site.","date":"1995","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8524640","citation_count":186,"is_preprint":false},{"pmid":"19561568","id":"PMC_19561568","title":"Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts).","date":"2009","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/19561568","citation_count":178,"is_preprint":false},{"pmid":"9154834","id":"PMC_9154834","title":"Discrete roles of the Spc1 kinase and the Atf1 transcription factor in the UV response of Schizosaccharomyces pombe.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9154834","citation_count":170,"is_preprint":false},{"pmid":"18094413","id":"PMC_18094413","title":"EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma.","date":"2007","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/18094413","citation_count":168,"is_preprint":false},{"pmid":"11826187","id":"PMC_11826187","title":"Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.","date":"2002","source":"The Journal of molecular diagnostics : JMD","url":"https://pubmed.ncbi.nlm.nih.gov/11826187","citation_count":144,"is_preprint":false},{"pmid":"9585506","id":"PMC_9585506","title":"Phosphorylation and association with the transcription factor Atf1 regulate localization of Spc1/Sty1 stress-activated kinase in fission yeast.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9585506","citation_count":139,"is_preprint":false},{"pmid":"9391101","id":"PMC_9391101","title":"Transcription factor Mts1/Mts2 (Atf1/Pcr1, Gad7/Pcr1) activates the M26 meiotic recombination hotspot in Schizosaccharomyces pombe.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9391101","citation_count":137,"is_preprint":false},{"pmid":"11992546","id":"PMC_11992546","title":"Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses.","date":"2002","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11992546","citation_count":116,"is_preprint":false},{"pmid":"11063792","id":"PMC_11063792","title":"Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11.","date":"2000","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/11063792","citation_count":116,"is_preprint":false},{"pmid":"25310977","id":"PMC_25310977","title":"The fungal aroma gene ATF1 promotes dispersal of yeast cells through insect vectors.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25310977","citation_count":113,"is_preprint":false},{"pmid":"22479460","id":"PMC_22479460","title":"MicroRNA-34c enhances murine male germ cell apoptosis through targeting ATF1.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22479460","citation_count":105,"is_preprint":false},{"pmid":"15884099","id":"PMC_15884099","title":"Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma.","date":"2005","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15884099","citation_count":105,"is_preprint":false},{"pmid":"17071615","id":"PMC_17071615","title":"Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17071615","citation_count":90,"is_preprint":false},{"pmid":"28505004","id":"PMC_28505004","title":"A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions.","date":"2017","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28505004","citation_count":89,"is_preprint":false},{"pmid":"22154050","id":"PMC_22154050","title":"EWSR1-ATF1 chimeric transcript in a myoepithelial tumor of soft tissue: a case report.","date":"2011","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22154050","citation_count":86,"is_preprint":false},{"pmid":"18375616","id":"PMC_18375616","title":"Transcription factors Pcr1 and Atf1 have distinct roles in stress- and Sty1-dependent gene regulation.","date":"2008","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/18375616","citation_count":81,"is_preprint":false},{"pmid":"17182615","id":"PMC_17182615","title":"Regulation of Schizosaccharomyces pombe Atf1 protein levels by Sty1-mediated phosphorylation and heterodimerization with Pcr1.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17182615","citation_count":80,"is_preprint":false},{"pmid":"7753552","id":"PMC_7753552","title":"Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7753552","citation_count":79,"is_preprint":false},{"pmid":"21876055","id":"PMC_21876055","title":"Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter.","date":"2011","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/21876055","citation_count":78,"is_preprint":false},{"pmid":"18300800","id":"PMC_18300800","title":"Primary intracerebral angiomatoid fibrous histiocytoma: report of a case with a t(12;22)(q13;q12) causing type 1 fusion of the EWS and ATF-1 genes.","date":"2008","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18300800","citation_count":78,"is_preprint":false},{"pmid":"12414794","id":"PMC_12414794","title":"ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12414794","citation_count":71,"is_preprint":false},{"pmid":"16227528","id":"PMC_16227528","title":"Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1.","date":"2005","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16227528","citation_count":66,"is_preprint":false},{"pmid":"15712185","id":"PMC_15712185","title":"EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.","date":"2005","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15712185","citation_count":66,"is_preprint":false},{"pmid":"17077290","id":"PMC_17077290","title":"Leptin signaling in neurotensin neurons involves STAT, MAP kinases ERK1/2, and p38 through c-Fos and ATF1.","date":"2006","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17077290","citation_count":65,"is_preprint":false},{"pmid":"12218455","id":"PMC_12218455","title":"Fusion of the FUS and ATF1 genes in a large, deep-seated angiomatoid fibrous histiocytoma.","date":"2002","source":"Diagnostic molecular pathology : the American journal of surgical pathology, part B","url":"https://pubmed.ncbi.nlm.nih.gov/12218455","citation_count":62,"is_preprint":false},{"pmid":"23945004","id":"PMC_23945004","title":"The ATF/CREB transcription factor Atf1 is essential for full virulence, deoxynivalenol production, and stress tolerance in the cereal pathogen Fusarium graminearum.","date":"2013","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/23945004","citation_count":59,"is_preprint":false},{"pmid":"28772210","id":"PMC_28772210","title":"LncRNA GHET1 activated by H3K27 acetylation promotes cell tumorigenesis through regulating ATF1 in hepatocellular carcinoma.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28772210","citation_count":57,"is_preprint":false},{"pmid":"10945975","id":"PMC_10945975","title":"BRCA1 physically and functionally interacts with ATF1.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10945975","citation_count":56,"is_preprint":false},{"pmid":"15247218","id":"PMC_15247218","title":"A cooperative role for Atf1 and Pap1 in the detoxification of the oxidative stress induced by glucose deprivation in Schizosaccharomyces pombe.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15247218","citation_count":56,"is_preprint":false},{"pmid":"10567368","id":"PMC_10567368","title":"Transcriptional regulation of the transforming growth factor-beta2 promoter by cAMP-responsive element-binding protein (CREB) and activating transcription factor-1 (ATF-1) is modulated by protein kinases and the coactivators p300 and CREB-binding protein.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10567368","citation_count":55,"is_preprint":false},{"pmid":"20661279","id":"PMC_20661279","title":"Genomic binding profiling of the fission yeast stress-activated MAPK Sty1 and the bZIP transcriptional activator Atf1 in response to H2O2.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20661279","citation_count":55,"is_preprint":false},{"pmid":"21098035","id":"PMC_21098035","title":"Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21098035","citation_count":54,"is_preprint":false},{"pmid":"31204011","id":"PMC_31204011","title":"Systematic Functional Interrogation of Genes in GWAS Loci Identified ATF1 as a Key Driver in Colorectal Cancer Modulated by a Promoter-Enhancer Interaction.","date":"2019","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31204011","citation_count":53,"is_preprint":false},{"pmid":"15491278","id":"PMC_15491278","title":"Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15491278","citation_count":53,"is_preprint":false},{"pmid":"17881729","id":"PMC_17881729","title":"Atf1 is a target of the mitogen-activated protein kinase Pmk1 and regulates cell integrity in fission yeast.","date":"2007","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/17881729","citation_count":52,"is_preprint":false},{"pmid":"24719331","id":"PMC_24719331","title":"Heme oxygenase-1 regulates dendritic cell function through modulation of p38 MAPK-CREB/ATF1 signaling.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24719331","citation_count":51,"is_preprint":false},{"pmid":"14654433","id":"PMC_14654433","title":"The Saccharomyces cerevisiae alcohol acetyl transferase gene ATF1 is a target of the cAMP/PKA and FGM nutrient-signalling pathways.","date":"2003","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/14654433","citation_count":48,"is_preprint":false},{"pmid":"22431512","id":"PMC_22431512","title":"RNAi keeps Atf1-bound stress response genes in check at nuclear pores.","date":"2012","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/22431512","citation_count":48,"is_preprint":false},{"pmid":"25312646","id":"PMC_25312646","title":"ATF1 modulates the heat shock response by regulating the stress-inducible heat shock factor 1 transcription complex.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25312646","citation_count":48,"is_preprint":false},{"pmid":"9675816","id":"PMC_9675816","title":"Transcriptional co-regulation of Saccharomyces cerevisiae alcohol acetyltransferase gene, ATF1 and delta-9 fatty acid desaturase gene, OLE1 by unsaturated fatty acids.","date":"1998","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9675816","citation_count":45,"is_preprint":false},{"pmid":"8627725","id":"PMC_8627725","title":"The CREB, ATF-1, and ATF-2 transcription factors from bovine leukemia virus-infected B lymphocytes activate viral expression.","date":"1996","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/8627725","citation_count":45,"is_preprint":false},{"pmid":"9160316","id":"PMC_9160316","title":"Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation.","date":"1997","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/9160316","citation_count":45,"is_preprint":false},{"pmid":"18948219","id":"PMC_18948219","title":"ATF-1 transcription factor regulates the expression of ccg-1 and cat-1 genes in response to fludioxonil under OS-2 MAP kinase in Neurospora crassa.","date":"2008","source":"Fungal genetics and biology : FG & B","url":"https://pubmed.ncbi.nlm.nih.gov/18948219","citation_count":44,"is_preprint":false},{"pmid":"22588066","id":"PMC_22588066","title":"Endobronchial pulmonary angiomatoid fibrous histiocytoma: two cases with EWSR1-CREB1 and EWSR1-ATF1 fusions.","date":"2012","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22588066","citation_count":44,"is_preprint":false},{"pmid":"10487921","id":"PMC_10487921","title":"Molecular mechanism of the multiple regulation of the Saccharomyces cerevisiae ATF1 gene encoding alcohol acetyltransferase.","date":"1999","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10487921","citation_count":44,"is_preprint":false},{"pmid":"23281395","id":"PMC_23281395","title":"EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23281395","citation_count":43,"is_preprint":false},{"pmid":"15448137","id":"PMC_15448137","title":"Atf1-Pcr1-M26 complex links stress-activated MAPK and cAMP-dependent protein kinase pathways via chromatin remodeling of cgs2+.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15448137","citation_count":43,"is_preprint":false},{"pmid":"18375981","id":"PMC_18375981","title":"Distinct regions of ATF/CREB proteins Atf1 and Pcr1 control recombination hotspot ade6-M26 and the osmotic stress response.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18375981","citation_count":43,"is_preprint":false},{"pmid":"23459838","id":"PMC_23459838","title":"What the EWSR1-ATF1 fusion has taught us about hyalinizing clear cell carcinoma.","date":"2013","source":"Head and neck pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23459838","citation_count":41,"is_preprint":false},{"pmid":"10731689","id":"PMC_10731689","title":"Role of Atf1 and Pap1 in the induction of the catalase gene of fission yeast schizosaccharomyces pombe.","date":"2000","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10731689","citation_count":41,"is_preprint":false},{"pmid":"9018131","id":"PMC_9018131","title":"Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1.","date":"1997","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/9018131","citation_count":40,"is_preprint":false},{"pmid":"18502752","id":"PMC_18502752","title":"Int6/eIF3e promotes general translation and Atf1 abundance to modulate Sty1 MAPK-dependent stress response in fission yeast.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18502752","citation_count":39,"is_preprint":false},{"pmid":"7843287","id":"PMC_7843287","title":"Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site.","date":"1995","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/7843287","citation_count":39,"is_preprint":false},{"pmid":"35477713","id":"PMC_35477713","title":"EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell Sarcoma.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35477713","citation_count":37,"is_preprint":false},{"pmid":"9569031","id":"PMC_9569031","title":"The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9569031","citation_count":37,"is_preprint":false},{"pmid":"8414969","id":"PMC_8414969","title":"In vitro phosphorylation studies of a conserved region of the transcription factor ATF1.","date":"1993","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8414969","citation_count":35,"is_preprint":false},{"pmid":"17565989","id":"PMC_17565989","title":"PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17565989","citation_count":34,"is_preprint":false},{"pmid":"9489722","id":"PMC_9489722","title":"Dominant negative ATF1 blocks cyclic AMP-induced neurite outgrowth in PC12D cells.","date":"1998","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9489722","citation_count":34,"is_preprint":false},{"pmid":"7479004","id":"PMC_7479004","title":"Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter.","date":"1995","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/7479004","citation_count":34,"is_preprint":false},{"pmid":"36791251","id":"PMC_36791251","title":"Inflammatory and Nested Testicular Sex Cord Tumor: A Novel Neoplasm With Aggressive Clinical Behavior and Frequent EWSR1::ATF1 Gene Fusions.","date":"2023","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/36791251","citation_count":33,"is_preprint":false},{"pmid":"32016322","id":"PMC_32016322","title":"Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion.","date":"2020","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32016322","citation_count":33,"is_preprint":false},{"pmid":"33917483","id":"PMC_33917483","title":"Blockade of AMPK-Mediated cAMP-PKA-CREB/ATF1 Signaling Synergizes with Aspirin to Inhibit Hepatocellular Carcinoma.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33917483","citation_count":32,"is_preprint":false},{"pmid":"33530829","id":"PMC_33530829","title":"NEDD4 triggers FOXA1 ubiquitination and promotes colon cancer progression under microRNA-340-5p suppression and ATF1 upregulation.","date":"2021","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/33530829","citation_count":31,"is_preprint":false},{"pmid":"16424113","id":"PMC_16424113","title":"Docosahexaenoic acid consumption inhibits deoxynivalenol-induced CREB/ATF1 activation and IL-6 gene transcription in mouse macrophages.","date":"2006","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/16424113","citation_count":31,"is_preprint":false},{"pmid":"28652406","id":"PMC_28652406","title":"Deciphering the role of the signal- and Sty1 kinase-dependent phosphorylation of the stress-responsive transcription factor Atf1 on gene activation.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28652406","citation_count":31,"is_preprint":false},{"pmid":"31488818","id":"PMC_31488818","title":"Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31488818","citation_count":30,"is_preprint":false},{"pmid":"20032302","id":"PMC_20032302","title":"The cell surface protein gene ecm33+ is a target of the two transcription factors Atf1 and Mbx1 and negatively regulates Pmk1 MAPK cell integrity signaling in fission yeast.","date":"2009","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20032302","citation_count":30,"is_preprint":false},{"pmid":"30047065","id":"PMC_30047065","title":"Clear Cell Odontogenic Carcinoma: Occurrence of EWSR1-CREB1 as Alternative Fusion Gene to EWSR1-ATF1.","date":"2018","source":"Head and neck pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30047065","citation_count":30,"is_preprint":false},{"pmid":"11313922","id":"PMC_11313922","title":"Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11313922","citation_count":29,"is_preprint":false},{"pmid":"24721473","id":"PMC_24721473","title":"EWSR1 and ATF1 rearrangements in clear cell odontogenic carcinoma: presentation of a case.","date":"2014","source":"Oral surgery, oral medicine, oral pathology and oral radiology","url":"https://pubmed.ncbi.nlm.nih.gov/24721473","citation_count":28,"is_preprint":false},{"pmid":"28259977","id":"PMC_28259977","title":"miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28259977","citation_count":28,"is_preprint":false},{"pmid":"16517477","id":"PMC_16517477","title":"Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection.","date":"2006","source":"Ultrastructural pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16517477","citation_count":28,"is_preprint":false},{"pmid":"28205618","id":"PMC_28205618","title":"ALD5, PAD1, ATF1 and ATF2 facilitate the catabolism of coniferyl aldehyde, ferulic acid and p-coumaric acid in Saccharomyces cerevisiae.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28205618","citation_count":27,"is_preprint":false},{"pmid":"18579531","id":"PMC_18579531","title":"ATF-1 is a hypoxia-responsive transcriptional activator of skeletal muscle mitochondrial-uncoupling protein 3.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18579531","citation_count":27,"is_preprint":false},{"pmid":"10574952","id":"PMC_10574952","title":"Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10574952","citation_count":26,"is_preprint":false},{"pmid":"25359601","id":"PMC_25359601","title":"Hyalinizing clear cell carcinoma with EWSR1-ATF1 fusion gene: report of three cases with molecular analyses.","date":"2014","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25359601","citation_count":26,"is_preprint":false},{"pmid":"32776307","id":"PMC_32776307","title":"LINC00665/miR-9-5p/ATF1 is a novel axis involved in the progression of colorectal cancer.","date":"2020","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/32776307","citation_count":25,"is_preprint":false},{"pmid":"29023897","id":"PMC_29023897","title":"ATF1 and RAS in exosomes are potential clinical diagnostic markers for cervical cancer.","date":"2017","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/29023897","citation_count":25,"is_preprint":false},{"pmid":"31604764","id":"PMC_31604764","title":"Transcription Factor Atf1 Regulates Expression of Cellulase and Xylanase Genes during Solid-State Fermentation of Ascomycetes.","date":"2019","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31604764","citation_count":24,"is_preprint":false},{"pmid":"30790638","id":"PMC_30790638","title":"Long non-coding RNA RP11-552M11.4 favors tumorigenesis and development of cervical cancer via modulating miR-3941/ATF1 signaling.","date":"2019","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/30790638","citation_count":24,"is_preprint":false},{"pmid":"19584054","id":"PMC_19584054","title":"The transcription factor Atf1 binds and activates the APC/C ubiquitin ligase in fission yeast.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19584054","citation_count":24,"is_preprint":false},{"pmid":"19776387","id":"PMC_19776387","title":"The presence and activation of two essential transcription factors (cAMP response element-binding protein and cAMP-dependent transcription factor ATF1) in the two-cell mouse embryo.","date":"2009","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/19776387","citation_count":24,"is_preprint":false},{"pmid":"9016641","id":"PMC_9016641","title":"Phosphorylation of ATF-1 enhances its DNA binding and transcription of the Na,K-ATPase alpha 1 subunit gene promoter.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9016641","citation_count":24,"is_preprint":false},{"pmid":"18309479","id":"PMC_18309479","title":"Flavour formation in fungi: characterisation of KlAtf, the Kluyveromyces lactis orthologue of the Saccharomyces cerevisiae alcohol acetyltransferases Atf1 and Atf2.","date":"2008","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/18309479","citation_count":24,"is_preprint":false},{"pmid":"9398163","id":"PMC_9398163","title":"ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element.","date":"1997","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9398163","citation_count":23,"is_preprint":false},{"pmid":"16327442","id":"PMC_16327442","title":"Association of the t(12;22)(q13;q12) EWS/ATF1 rearrangement with polyphenotypic round cell sarcoma of bone: a case report.","date":"2005","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16327442","citation_count":22,"is_preprint":false},{"pmid":"11464282","id":"PMC_11464282","title":"A repetitive element containing a critical tyrosine residue is required for transcriptional activation by the EWS/ATF1 oncogene.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11464282","citation_count":22,"is_preprint":false},{"pmid":"26149214","id":"PMC_26149214","title":"The human ATF1 rs11169571 polymorphism increases essential hypertension risk through modifying miRNA binding.","date":"2015","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/26149214","citation_count":21,"is_preprint":false},{"pmid":"9704883","id":"PMC_9704883","title":"5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine.","date":"1998","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9704883","citation_count":21,"is_preprint":false},{"pmid":"19836238","id":"PMC_19836238","title":"Stress-induced phosphorylation of S. pombe Atf1 abrogates its interaction with F box protein Fbh1.","date":"2009","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/19836238","citation_count":21,"is_preprint":false},{"pmid":"28559020","id":"PMC_28559020","title":"Establishment and characterization of a clear cell odontogenic carcinoma cell line with EWSR1-ATF1 fusion gene.","date":"2017","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28559020","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51076,"output_tokens":7246,"usd":0.130959,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16362,"output_tokens":6666,"usd":0.12423,"stage2_stop_reason":"end_turn"},"total_usd":0.255189,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"ATF-1 contains a consensus PKA phosphorylation site and is capable of dimerizing with CREB; both ATF-1 homodimers and ATF-1/CREB heterodimers bind to the CRE but not the phorbol ester response element. ATF-1 mediates transcriptional activation in response to cAMP-dependent protein kinase A, and is more responsive than CREB to cAMP due to its smaller effect on basal expression.\",\n      \"method\": \"cDNA sequencing, in vitro dimerization assay, EMSA/DNA binding, transient transfection reporter assay with PKA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biochemical methods (DNA binding, dimerization, reporter assay, sequence analysis) in a single foundational study; widely replicated\",\n      \"pmids\": [\"1655749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The t(12;22)(q13;q12) chromosomal translocation fuses the N-terminal domain of EWS to the bZIP domain of ATF-1, producing a chimeric EWS/ATF1 protein associated with malignant melanoma of soft parts (clear cell sarcoma).\",\n      \"method\": \"RT-PCR, cDNA cloning, sequencing of hybrid transcripts from tumor specimens\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct molecular cloning and sequencing of fusion transcripts, replicated across multiple independent studies\",\n      \"pmids\": [\"8401579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"ATF1 contains key serine residues required for a phosphorylation-induced conformational change; phosphorylation is modulated by ATF1 homodimerization and by ATF1 binding to DNA. One critical serine is not conserved in CREB/CREM, suggesting a specialized function of ATF1.\",\n      \"method\": \"In vitro phosphorylation assay, mutagenesis of serine residues, DNA binding stability assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro phosphorylation and mutagenesis in a single study, no cellular validation reported in abstract\",\n      \"pmids\": [\"8414969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"ATF-1 and CREB-1 bind constitutively to the HIF-1 DNA recognition site as homodimers or heterodimers, revealing a new binding specificity for ATF-1/CREB-1. PKA signaling (but not PKC) is involved in oxygen-sensing activity at this element.\",\n      \"method\": \"EMSA with competitor oligonucleotides and monoclonal antibody supershift, recombinant protein binding assay, reporter gene assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal EMSA with antibody supershift and recombinant protein, plus reporter assay; single lab\",\n      \"pmids\": [\"8524640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"EWS/ATF1 fusion protein acts as a strong constitutive transcriptional activator of some ATF1-binding promoters and represses others; the pattern of promoter activation in transfected cells correlates with promoter activity in MMSP-derived cell lines, indicating endogenous EWS/ATF1 de-regulates transcription.\",\n      \"method\": \"Transient transfection, reporter gene assay in JEG3 cells and MMSP cell lines\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays in multiple cell contexts, correlative but mechanistically informative; single lab\",\n      \"pmids\": [\"7753552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"FGF and cellular stress activate CREB and ATF-1 via p38 MAP kinase → MAPKAP kinase-2 signaling. MAPKAP kinase-2 phosphorylates CREB at Ser133 in vitro, and FGF/stress-induced phosphorylation of both CREB and ATF-1 is blocked by the p38 inhibitor SB 203580 at similar concentrations. Transfection of RK/p38 (but not p44 MAP kinase) activates Gal4-CREB-dependent transcription via Ser133.\",\n      \"method\": \"In vitro kinase assay, dominant negative Ras transfection, specific kinase inhibitor (SB203580), Gal4 reporter assay, cell fractionation kinase activity assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro phosphorylation assay plus cellular pharmacological inhibition plus dominant-negative experiments plus reporter assay; multiple orthogonal methods\",\n      \"pmids\": [\"8887554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"ATF-1 binds the ZII element of the EBV BZLF1 promoter (core motif TGACATCA) and transactivates it; deletion of ATF-1's DNA binding domain abolishes this transactivation. UV cross-linking identified ATF-1 as a 46/51 kDa protein within ZII-binding complexes.\",\n      \"method\": \"EMSA, UV cross-linking, antibody immunoprecipitation, cotransfection reporter assay with deletion mutants\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA, UV cross-linking and reporter assay with domain deletion mutants; single lab\",\n      \"pmids\": [\"9018131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Phosphorylation of ATF-1 at Ser63 enhances its DNA binding activity in both homodimeric and heterodimeric (ATF-1/CREB) forms, and stimulates in vitro transcription from the Na,K-ATPase α1 subunit gene promoter, which has an asymmetrical ATF/CRE site.\",\n      \"method\": \"In vitro dephosphorylation, EMSA, in vitro transcription assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical assays (EMSA + transcription), single lab, no mutagenesis of Ser63 directly reported in this abstract\",\n      \"pmids\": [\"9016641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"ATF1 and CREB bind to two ATF/CRE motifs in the histone H4 promoter; ATF1 exists as two isoforms that partition differentially between nuclear matrix and non-matrix compartments, and both Site I and Site IV (nuclear matrix-associated) ATF/CRE motifs are required for ATF1- and CREB-induced transactivation of the H4 promoter.\",\n      \"method\": \"Protein-DNA interaction assays (EMSA), subnuclear fractionation, site-directed mutagenesis, transactivation reporter assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical methods (EMSA, fractionation, mutagenesis, reporter), single lab\",\n      \"pmids\": [\"9398163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"EWS/ATF1 transcriptional activation does not require dimerization with other ATF family members; the EWS activation domain (EAD) can act directly and determinants of transactivation are dispersed throughout the EAD and cooperate synergistically.\",\n      \"method\": \"Mutational analysis in mammalian cells, reporter assay, yeast transactivation assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis with reporter assays across mammalian and yeast systems; single lab\",\n      \"pmids\": [\"9569031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Dominant-negative ATF1 (point mutation in DNA binding domain) expressed stably in PC12D cells suppresses CRE reporter activity, reduces immediate early gene mRNA induction by forskolin, and blocks cAMP-induced neurite outgrowth, without affecting NGF-induced differentiation. This implicates the CREB/ATF1 heterodimer specifically in cAMP-dependent neuronal differentiation.\",\n      \"method\": \"Stable transfection of dominant-negative ATF1RL, CRE reporter assay, Northern blot for immediate early genes, morphological assessment of neurite outgrowth\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — stable cell line loss-of-function with defined phenotypic readout and reporter assay; single lab\",\n      \"pmids\": [\"9489722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Transcription of the TGF-β2 gene is dependent on CRE/ATF sites bound by CREB and ATF-1; the coactivators p300 and CBP up-regulate TGF-β2 promoter activity when CREB and ATF-1 are expressed together with kinases that phosphorylate CREB at Ser133 and ATF-1 at Ser63. Serine 133-phosphorylated CREB accumulates in nuclei of differentiated but not undifferentiated F9 cells.\",\n      \"method\": \"Transient transfection, co-expression with kinases, reporter assay, western blot for phospho-CREB\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter + co-expression + western blot; single lab, multiple methods\",\n      \"pmids\": [\"10567368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"BRCA1 physically interacts with ATF1 via the BRCA1 RING finger domain, as demonstrated in vitro, in yeast two-hybrid, and by co-immunoprecipitation in human cells. BRCA1 stimulates transcription from a CRE reporter and from the TNF-α promoter in a CRE-dependent manner.\",\n      \"method\": \"Yeast two-hybrid, in vitro pull-down, co-immunoprecipitation in human cells, transient transfection reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal interactions confirmed in three systems (yeast, in vitro, human cells) with functional reporter validation\",\n      \"pmids\": [\"10945975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Phosphorylation of serine 266 in the EWS IQ domain regulates the transcriptional activity of EWS/ATF1 (and EWS/FLI1). Elimination of phosphorylation significantly reduced DNA binding and reporter activation; phosphomimetic mutation partially restored wild-type activity. Phosphorylation also mediates cellular compartmentalization of EWS/ATF1.\",\n      \"method\": \"Mutagenesis, EMSA, luciferase reporter assay, cellular fractionation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro DNA binding + mutagenesis + reporter assay; single lab\",\n      \"pmids\": [\"11313922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Degenerate Hexapeptide Repeats (DHRs) in the EWS activation domain contain conserved tyrosines that are required for transcriptional activation by EWS/ATF1; small regions (~30 residues) of the EAD trans-cooperate to produce potent tyrosine-dependent transactivation.\",\n      \"method\": \"Mutational analysis of EAD repeat elements, reporter assay in mammalian cells\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic mutagenesis with reporter assays; single lab\",\n      \"pmids\": [\"11464282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"MSK1 and MSK2 are required for stress-induced phosphorylation of both CREB and ATF1 in primary fibroblasts. Mitogen-induced phosphorylation of CREB and ATF1 is greatly reduced but not abolished in MSK1/MSK2 double-knockout cells. Loss of both MSK1 and MSK2 reduces c-fos and junB transcription by ~50% in response to anisomycin or UV-C.\",\n      \"method\": \"Mouse MSK1/MSK2 single and double knockouts, immunoblot for phospho-CREB/ATF1, Northern blot for immediate early genes\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout (double KO) with biochemical and transcriptional readouts; strong causal evidence\",\n      \"pmids\": [\"11909979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ATF1 phosphorylation at Ser63 by MSK1 (activated downstream of ERK1/2) is required for EGF-induced c-jun promoter activation. A Ser63→Ala ATF1 mutant blocks EGF induction of transfected c-jun; kinase-dead MSK1 also blocks EGF induction. The ERK pathway (blocked by MEK1 inhibitor U0126 or dominant-negative MEK1) is required for MSK1 activation and ATF1 phosphorylation.\",\n      \"method\": \"Site-directed mutagenesis of ATF1 Ser63, dominant-negative kinase constructs, pharmacological inhibitors, reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of phosphorylation site combined with dominant-negative and pharmacological approaches with defined reporter readout; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12414794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Intracellular delivery of an anti-ATF1 single-chain antibody (scFv4) into the CCS cell line SU-CCS-1 reduces CRE-driven reporter activity by 90% and causes loss of viability and apoptosis, demonstrating that EWS/ATF1 DNA-binding activity is required for maintenance of CCS tumor cell viability.\",\n      \"method\": \"Intracellular scFv antibody delivery, CRE reporter assay, TUNEL/flow cytometry apoptosis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional antibody knockdown with multiple cellular readouts; single lab\",\n      \"pmids\": [\"10574952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ATF-1 is an essential transcriptional activator of NOX1 (NADPH oxidase 1) in vascular smooth muscle cells. PGF2α- or PDGF-induced NOX1 mRNA induction is suppressed by mitochondrial respiratory chain inhibitors acting upstream of ATF-1 phosphorylation; ATF-1 siRNA knockdown reduces NOX1 induction, and ATF-1 overexpression rescues NOX1 induction suppressed by oligomycin.\",\n      \"method\": \"Luciferase reporter assay, RNA interference (siRNA), overexpression rescue, pharmacological inhibitors\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi knockdown + overexpression rescue + reporter assay; single lab, multiple methods\",\n      \"pmids\": [\"15491278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Loss of CREB/ATF1 (by siRNA) blocks adipogenic conversion of 3T3-L1 cells even in the presence of ectopically expressed C/EBPα, C/EBPβ, or PPARγ2 individually, and prevents expression of PPARγ, C/EBPα, and adiponectin, indicating CREB/ATF1 acts downstream of or in parallel with master adipogenic regulators.\",\n      \"method\": \"siRNA depletion, ectopic expression of adipogenic regulators, adipogenesis assays (lipid accumulation, adipokine expression)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi loss-of-function with epistasis via ectopic expression rescue; single lab\",\n      \"pmids\": [\"17071615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PIAS3 interacts with ATF1 (identified by yeast two-hybrid screening) and antagonizes ATF1's function as a transcriptional repressor of the ferritin H ARE by decreasing ATF1 binding to the ARE. ATF1 is sumoylated, but PIAS3 does not appear to play a major role in SUMO1-mediated ATF1 sumoylation. ATF1 knockdown increases ferritin H expression.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, EMSA, siRNA knockdown, reporter assay, sumoylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid, Co-IP, EMSA, and RNAi in combination; single lab\",\n      \"pmids\": [\"17565989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ATF-1, identified via a transcription factor array screen, binds a 10-bp region of the UCP3 promoter (identified by site-directed mutagenesis and ChIP) and is required for hypoxia-induced UCP3 upregulation. ATF-1 is phosphorylated during hypoxia via p38 MAP kinase; shRNA knockdown of ATF-1 prevents hypoxia-mediated UCP3 upregulation.\",\n      \"method\": \"Transcription factor cDNA array screen, luciferase reporter + site-directed mutagenesis, ChIP, shRNA knockdown, western blot for phospho-ATF-1, p38 pharmacological inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal methods including mutagenesis, ChIP, shRNA, and pharmacological inhibition in a single study\",\n      \"pmids\": [\"18579531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RSK2 phosphorylates ATF1 at Ser-63 and enhances ATF1 transcriptional activity. In vitro pulldown assays combined with crystal structure docking show eriodictyol binds the RSK2 N-terminal kinase domain, inhibiting RSK2 activity and ATF1 phosphorylation. Knockdown of RSK2 or ATF1 suppresses Ras-mediated focus formation, indicating RSK2-ATF1 signaling drives neoplastic transformation.\",\n      \"method\": \"In vitro kinase assay, crystal structure docking, in vitro pulldown, RNAi knockdown, focus formation assay, reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay identifying novel substrate, structural docking + pulldown + RNAi functional validation; multiple orthogonal methods\",\n      \"pmids\": [\"21098035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"miR-34c directly binds the 3'UTR of ATF1 and reduces ATF1 protein (but not mRNA) levels; ATF1 knockdown decreases the Bcl-2/Bax ratio and induces apoptosis in GC-2 cells; miR-34c inhibition cannot rescue apoptosis in ATF1-knockdown cells, placing ATF1 downstream of miR-34c in the regulation of germ cell apoptosis.\",\n      \"method\": \"Luciferase 3'UTR reporter assay, siRNA knockdown, miR-34c inhibitor, western blot, flow cytometry for apoptosis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — 3'UTR reporter + epistasis rescue experiment + knockdown; single lab\",\n      \"pmids\": [\"22479460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"EWS/ATF1 expression in neural crest-derived cells in mice induces CCS-like sarcomas; EWS/ATF1 directly induces Fos expression in an ERK-independent manner, and FOS is required for EWS/ATF1-associated tumor cell proliferation (FOS siRNA attenuates growth).\",\n      \"method\": \"Inducible transgenic mouse model, lineage tracing, siRNA knockdown, gene expression analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible mouse model with lineage tracing plus siRNA functional validation; multiple orthogonal approaches\",\n      \"pmids\": [\"23281395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ATF1 interacts with HSF1 and is recruited to the HSP70 promoter in response to heat shock. The HSF1 transcription complex requires ATF1 phosphorylation for incorporation of BRG1 and p300/CBP. ATF1-BRG1 promotes active chromatin and HSP70 expression during heat shock; ATF1-p300/CBP accelerates shutdown of HSF1 DNA-binding during recovery, possibly via HSF1 acetylation. ATF1 markedly affects heat shock resistance.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq, reporter assay, domain deletion/phosphorylation mutants, RNAi knockdown, heat shock survival assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, ChIP-seq, mutagenesis, and functional assays in combination; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"25312646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"EWSR1-ATF1 displays a distinct DNA binding pattern that requires the EWSR1 domain and promotes ATF1 retargeting to new distal enhancer sites, leading to chromatin activation and establishment of a 3D regulatory network controlling oncogenic and differentiation gene signatures. EWSR1-ATF1 depletion reconfigures 3D connectivity and activates neural crest developmental programs.\",\n      \"method\": \"ChIP-seq, ATAC-seq, Hi-C/3D chromatin conformation, EWSR1-ATF1 depletion, RNA-seq in CCS cells\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal epigenomic and 3D chromatin methods combined with depletion experiments; single study with comprehensive mechanistic depth\",\n      \"pmids\": [\"35477713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ATF1 facilitates cell proliferation and promotes CRC xenograft growth by affecting cell apoptosis. Two risk variants in the ATF1 promoter and first intron facilitate a promoter-enhancer interaction mediated by SP1 and GATA3, upregulating ATF1 expression. ChIP-seq shows ATF1 activates a subset of target genes including BRAF, NRAS, MYC, BIRC2, and MAML2 related to apoptosis, Wnt, TGF-β, and MAPK pathways.\",\n      \"method\": \"RNAi screen, xenograft growth assay, ChIP-seq, RNA-seq, chromatin conformation assay, luciferase reporter\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi screen + ChIP-seq + RNA-seq + reporter; single lab, multiple methods but complex composite study\",\n      \"pmids\": [\"31204011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"EWS/ATF1 binds cell type-specific enhancer regions in CCS cells; epigenetic silencing at these enhancers induces senescence and inhibits CCS cell growth through altered EWS/ATF1 binding. EWS/ATF1 expression induces oncogene-induced senescence in most cell types but prevents it in sarcoma-permissive cells, and Tppp3-expressing cells in peripheral nerves are identified as a cell-of-origin.\",\n      \"method\": \"iPSC reprogramming, inducible EWS/ATF1 expression, ChIP-seq, epigenetic silencing, lineage tracing\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible system, ChIP-seq, and lineage tracing with functional epigenetic perturbation; multiple orthogonal methods\",\n      \"pmids\": [\"31488818\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATF1 is a bZIP transcription factor of the CREB/ATF family that binds CRE elements as homodimers or heterodimers with CREB, and is activated by phosphorylation at Ser63 (by MSK1, RSK2, and MAPKAP kinase-2 downstream of p38, ERK, and cAMP/PKA pathways), which enhances its DNA binding, recruits co-activators p300/CBP, and drives transcription of target genes including c-jun, NOX1, UCP3, and HSP70; in cancer, the EWS/ATF1 chromosomal fusion protein constitutively activates ATF-binding promoters, retargets ATF1 to novel distal enhancers via the EWSR1 domain, rewires 3D chromatin architecture to establish oncogenic gene programs, and is required for CCS tumor cell viability.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ATF1 is a bZIP transcription factor of the CREB/ATF family that binds CRE/ATF DNA elements as homodimers or as heterodimers with CREB and drives cAMP- and stress-responsive transcription [#0]. Its activity is gated by phosphorylation at Ser63, which induces a conformational change, enhances DNA binding by both homo- and heterodimers, and stimulates transcription from ATF/CRE promoters [#2, #7]; this phosphorylation is executed by multiple kinases converging from distinct signaling inputs — MAPKAP kinase-2 downstream of p38 upon FGF/stress [#5], MSK1/MSK2 in response to stress and mitogens [#15], MSK1 downstream of ERK1/2 for EGF-induced c-jun activation [#16], and RSK2, which couples ATF1 to Ras-mediated neoplastic transformation [#22]. Through these inputs ATF1 controls a broad target program: it activates c-jun [#16], NOX1 in vascular smooth muscle [#18], hypoxia-induced UCP3 [#21], and TGF-\\u03b22 via recruitment of p300/CBP coactivators [#11], and it represses the ferritin H antioxidant-response element, an activity antagonized by PIAS3 [#20]. ATF1 is integral to cellular stress and differentiation responses, partnering with HSF1 to recruit BRG1 and p300/CBP to the HSP70 promoter during heat shock [#25], and acting with CREB as a required factor in cAMP-dependent neuronal differentiation [#10] and adipogenesis [#19]. ATF1 also interacts physically with BRCA1, which stimulates CRE-dependent transcription [#12]. In cancer, the t(12;22) translocation fuses the EWS N-terminal activation domain to the ATF1 bZIP domain, producing EWS/ATF1, a constitutive transcriptional activator that causes clear cell sarcoma [#1, #4]; EWS/ATF1 DNA-binding is required for tumor cell viability [#17], retargets ATF1 to novel distal enhancers and rewires 3D chromatin architecture to establish oncogenic gene programs [#26, #28], and induces FOS to drive proliferation [#24].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Established ATF1 as a CRE-binding bZIP factor that dimerizes with CREB and mediates cAMP/PKA-responsive transcription, defining its founding identity.\",\n      \"evidence\": \"cDNA sequencing, in vitro dimerization, EMSA, and PKA-driven reporter assays\",\n      \"pmids\": [\"1655749\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous target genes not yet identified\", \"In vivo physiological role unaddressed\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Identified the t(12;22) EWS/ATF1 fusion linking the ATF1 bZIP domain to the EWS activation domain in clear cell sarcoma, opening the oncogenic dimension of ATF1 biology.\",\n      \"evidence\": \"RT-PCR and cDNA cloning/sequencing of fusion transcripts from tumor specimens\",\n      \"pmids\": [\"8401579\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional consequences of the fusion not yet defined\", \"Cell of origin unknown\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Defined critical serine residues whose phosphorylation induces a conformational change modulated by dimerization and DNA binding, with one serine unique to ATF1, hinting at a specialized activation mode.\",\n      \"evidence\": \"In vitro phosphorylation, serine mutagenesis, and DNA binding stability assays\",\n      \"pmids\": [\"8414969\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No cellular validation in this study\", \"Responsible kinase not identified\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Showed EWS/ATF1 acts as a strong constitutive activator (and selective repressor) of ATF1-binding promoters, mechanistically distinguishing the fusion from wild-type ATF1.\",\n      \"evidence\": \"Transient transfection reporter assays in JEG3 and MMSP cell lines\",\n      \"pmids\": [\"7753552\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous fusion target genes not mapped\", \"Correlative promoter activity, not direct binding\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Placed ATF1 phosphorylation downstream of the p38 MAPK \\u2192 MAPKAP kinase-2 cascade in response to FGF and cellular stress, establishing a stress-signaling input.\",\n      \"evidence\": \"In vitro kinase assay, dominant-negative Ras, SB203580 inhibition, Gal4 reporter assays\",\n      \"pmids\": [\"8887554\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ATF1 (vs CREB) phosphorylation site detail limited\", \"Downstream target genes not enumerated\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrated that Ser63 phosphorylation enhances ATF1 DNA binding and stimulates transcription, identifying the key activating modification.\",\n      \"evidence\": \"In vitro dephosphorylation, EMSA, and in vitro transcription from the Na,K-ATPase \\u03b11 promoter\",\n      \"pmids\": [\"9016641\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Ser63 mutagenesis not reported here\", \"Cellular kinase responsible not assigned\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Extended ATF1's promoter repertoire to viral (EBV BZLF1 ZII) and cellular (histone H4) targets and showed isoform-specific subnuclear partitioning, broadening its functional context.\",\n      \"evidence\": \"EMSA, UV cross-linking, IP, subnuclear fractionation, and reporter assays with deletion/mutagenesis\",\n      \"pmids\": [\"9018131\", \"9398163\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional significance of isoform partitioning unclear\", \"Single-lab promoter studies\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Dissected the EWS activation domain of the fusion, showing transactivation is dimerization-independent with determinants dispersed across the EAD acting synergistically.\",\n      \"evidence\": \"Mutational analysis with reporter assays in mammalian and yeast systems\",\n      \"pmids\": [\"9569031\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Coactivators recruited by the EAD not identified\", \"Endogenous targets untested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrated that EWS/ATF1 DNA-binding activity is essential for clear cell sarcoma tumor cell survival, validating it as a therapeutic dependency.\",\n      \"evidence\": \"Intracellular anti-ATF1 scFv delivery into SU-CCS-1 cells with CRE reporter and apoptosis assays\",\n      \"pmids\": [\"10574952\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of cell death downstream of fusion not defined\", \"Single cell line\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Linked ATF1/CREB and p300/CBP coactivation to TGF-\\u03b22 transcription, tying ATF1 phosphorylation to coactivator-dependent gene induction during differentiation.\",\n      \"evidence\": \"Transient transfection, kinase co-expression, reporter assays, phospho-CREB western blot\",\n      \"pmids\": [\"10567368\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ATF1 occupancy at the TGF-\\u03b22 promoter not shown by ChIP\", \"Relative ATF1 vs CREB contribution unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified BRCA1 as a direct physical partner of ATF1 that stimulates CRE-dependent transcription, connecting ATF1 to a tumor-suppressor protein.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro pull-down, co-IP in human cells, and CRE/TNF-\\u03b1 reporter assays\",\n      \"pmids\": [\"10945975\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context of the interaction unclear\", \"Effect on endogenous BRCA1 target genes untested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Refined fusion regulation by showing EWS Ser266 phosphorylation and conserved EAD tyrosines in hexapeptide repeats are required for EWS/ATF1 transactivation and compartmentalization.\",\n      \"evidence\": \"Mutagenesis, EMSA, luciferase reporter assays, and cellular fractionation\",\n      \"pmids\": [\"11313922\", \"11464282\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase phosphorylating Ser266 not identified\", \"Single-lab biochemical studies\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Genetically assigned MSK1/MSK2 as the kinases mediating stress- and mitogen-induced CREB/ATF1 phosphorylation and downstream immediate-early gene transcription.\",\n      \"evidence\": \"MSK1/MSK2 single and double knockout mice with phospho-immunoblot and Northern blot readouts\",\n      \"pmids\": [\"11909979\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Residual phosphorylation indicates additional kinases\", \"ATF1-specific (vs CREB) target effects not separated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Established the ERK \\u2192 MSK1 \\u2192 ATF1 Ser63 axis as required for EGF-induced c-jun activation, defining a specific mitogenic output of ATF1.\",\n      \"evidence\": \"Ser63\\u2192Ala mutagenesis, kinase-dead MSK1, U0126/dominant-negative MEK1, and reporter assays\",\n      \"pmids\": [\"12414794\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous c-jun occupancy by ATF1 not directly mapped\", \"Single-lab reporter system\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified NOX1 as an ATF1 target in vascular smooth muscle, coupling mitochondrial/redox signaling to ATF1-dependent NADPH oxidase induction.\",\n      \"evidence\": \"Luciferase reporter, ATF1 siRNA, overexpression rescue, and pharmacological inhibitors\",\n      \"pmids\": [\"15491278\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ATF1 binding to NOX1 promoter by ChIP not shown\", \"Single cell type\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Placed CREB/ATF1 as an essential factor for adipogenic conversion acting downstream of or parallel to master adipogenic regulators.\",\n      \"evidence\": \"siRNA depletion with ectopic expression of C/EBP and PPAR\\u03b3 and adipogenesis assays in 3T3-L1 cells\",\n      \"pmids\": [\"17071615\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct adipogenic target genes of ATF1 not defined\", \"ATF1 vs CREB contribution not separated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified PIAS3 as an ATF1 interactor antagonizing ATF1's repressor function at the ferritin H ARE and showed ATF1 is SUMOylated, revealing repressive and post-translational regulatory facets.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, EMSA, siRNA, reporter, and sumoylation assays\",\n      \"pmids\": [\"17565989\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional role of ATF1 SUMOylation unresolved\", \"PIAS3-ATF1 interaction not validated in vivo\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined ATF1 as a direct, p38-phosphorylated activator of hypoxia-induced UCP3, mapping a precise promoter element and linking ATF1 to metabolic adaptation.\",\n      \"evidence\": \"TF array screen, reporter mutagenesis, ChIP, shRNA, phospho-immunoblot, p38 inhibition\",\n      \"pmids\": [\"18579531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality across tissues untested\", \"Cofactors at UCP3 promoter not identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified RSK2 as a Ser63 ATF1 kinase whose activity drives Ras-mediated transformation, providing a pharmacologically targetable ATF1 signaling node.\",\n      \"evidence\": \"In vitro kinase assay, structural docking of eriodictyol, pulldown, RNAi, and focus formation assay\",\n      \"pmids\": [\"21098035\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo tumor relevance of RSK2-ATF1 axis untested here\", \"ATF1 target genes mediating transformation undefined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Placed ATF1 as a direct miR-34c target controlling the Bcl-2/Bax ratio and germ cell apoptosis, revealing post-transcriptional regulation of ATF1 levels.\",\n      \"evidence\": \"3'UTR luciferase reporter, siRNA, miR-34c inhibitor, western blot, apoptosis flow cytometry\",\n      \"pmids\": [\"22479460\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct apoptotic target genes of ATF1 not mapped\", \"Single cell model\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated in vivo that EWS/ATF1 in neural crest cells induces CCS-like sarcomas and directly drives FOS expression required for proliferation, establishing an oncogenic transcriptional output.\",\n      \"evidence\": \"Inducible transgenic mouse model, lineage tracing, and FOS siRNA knockdown\",\n      \"pmids\": [\"23281395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of direct fusion targets not enumerated\", \"Mechanism of ERK-independent Fos induction unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Revealed ATF1's role in the heat-shock response, where it partners with HSF1 and, in a phosphorylation-dependent manner, recruits BRG1 and p300/CBP to control HSP70 chromatin state and heat resistance.\",\n      \"evidence\": \"Co-IP, ChIP-seq, reporter assays, domain/phospho mutants, RNAi, and heat-shock survival assays\",\n      \"pmids\": [\"25312646\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HSF1 acetylation by ATF1-p300 is direct unproven\", \"Generality beyond HSP70 untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed risk-variant-driven upregulation of ATF1 promotes colorectal cancer growth and that ATF1 directly activates a set of oncogenic targets, extending its tumor-promoting role beyond the fusion context.\",\n      \"evidence\": \"RNAi screen, xenograft assays, ChIP-seq, RNA-seq, chromatin conformation, and reporter assays\",\n      \"pmids\": [\"31204011\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Composite study with complex causal chains\", \"Direct vs indirect target distinction incomplete\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Resolved how the EWSR1 domain reprograms ATF1, retargeting it to novel distal enhancers and rewiring 3D chromatin to establish oncogenic and differentiation gene networks in CCS, with depletion reconfiguring connectivity and reactivating neural crest programs.\",\n      \"evidence\": \"ChIP-seq, ATAC-seq, Hi-C, EWSR1-ATF1 depletion, and RNA-seq in CCS cells; complemented by iPSC/enhancer silencing and lineage tracing (PMID 31488818)\",\n      \"pmids\": [\"35477713\", \"31488818\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of enhancer selection by the EWSR1 domain not fully defined\", \"Translational targetability of the rewired network untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse upstream kinase inputs are integrated to produce context-specific ATF1 target gene selection, and how wild-type ATF1 versus the EWS/ATF1 fusion differentially engage chromatin and coactivators, remain incompletely defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of signal-to-target specificity\", \"Genome-wide wild-type ATF1 occupancy map limited\", \"Structural basis of EWS-domain-directed enhancer retargeting unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 4, 11, 18, 21, 25, 27]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 7, 8, 21, 26]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 11, 13]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 16, 21, 25]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 15, 16, 22]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [5, 21, 25]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 4, 24, 26, 28]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [10, 19]}\n    ],\n    \"complexes\": [\"CREB/ATF1 dimer\", \"HSF1 transcription complex (HSP70 promoter)\"],\n    \"partners\": [\"CREB1\", \"EWSR1\", \"BRCA1\", \"PIAS3\", \"HSF1\", \"p300/CBP\", \"BRG1\", \"MSK1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}